SECURITIES INVESTIGATION

CHEMED CORPORATION INVESTOR ALERT

JOIN OUR INVESTIGATION

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result.

40+ YEARS SECURITIES & DERIVATIVE LITIGATION EXPERIENCE
EXPERIENCE YOU CAN TRUST NEVER ANY MONEY OUT OF YOUR OWN POCKET
FREE • CONFIDENTIAL • NO OBLIGATION

CONTACT US NOW

ABOUT THIS INVESTIGATION

WHAT SHAREHOLDERS NEED TO KNOW:

On August 13, 2026, The Capital Forum released a report alleging that Chemed may be overbilling Medicare for continuous home care by tens of millions of dollars annually. Chemed previously entered into a $75 million settlement and a 5-year corporate integrity agreement with the Department of Health and Human Services for similar false Medicare claims.

HOW TO REACH US:

If you own Chemed common stock and you wish to discuss this investigation—at no cost for you—please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

JOIN THE INVESTIGATION

A Scott+Scott attorney will contact you within one business day – confidential, no cost, no obligation – to discuss your options.

HOW IT WORKS

Three simple steps. Free to start, no obligation, and no fee unless the court approves.

STEP 01

THREE SIMPLE STEPS. FREE TO START, NO OBLIGATION.

TAKES LESS THAN 2 MINUTES.

STEP 02

ATTORNEY CONTACTS YOU

SCOTT+SCOTT PARTNER JOSEPH PETTIGREW WILL CONTACT YOU TO DISCUSS YOUR OPTIONS.

STEP 03

JOIN THE INVESTIGATION

IF YOU QUALIFY, WE HANDLE EVERYTHING.

THE BOTTOM LINE:

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result.  Attorney Joseph A. Pettigrew is heading the investigation

Related Topics
SECURITIES LITIGATION ABOUT SCOTT+SCOTT
$2.3 Billion Settlement In re Foreign Exchange Benchmark Rates Antitrust Litigation
$500 Million Settlement In re Alphabet Inc. Shareholder Derivative Litigation
$190 Million Settlement In re Facebook Inc. Derivative Litigation
Previous results do not guarantee similar outcomes in other cases.
As Featured In
Joseph A. Pettigrew

Joseph A. Pettigrew

Partner Securities, Shareholder & Derivatives Litigation

Mr. Pettigrew is a Partner at Scott+Scott, working with attorneys across multiple Scott+Scott offices and practice areas. His practice areas include shareholder derivative, securities, consumer, and other complex litigation.

View Full Bio

FREQUENTLY ASKED QUESTIONS

What is this ongoing investigation into Chemed about?

According to our investigation, owners of Chemed common stock have been impacted by allegations that Chemed is overbilling Medicare for tens of millions of dollars each year for continuous home care services.  Scott+Scott has a decades-long track record in fighting for corporate governance and monetary recoveries on behalf of companies and their shareholders.

How does this Scott+Scott investigation work?

Joining our investigation is easy and at no cost for you.  By filling out the form below, we will let you know your rights as a Chemed shareholder, and how the process works and what you can expect.  If you currently own Chemed stock, we look forward to hearing from you. 

To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit www.scott-scott.com. 

Attorney Advertising